» Articles » PMID: 35292091

Dynamic Liquid Biopsy Components As Predictive and Prognostic Biomarkers in Colorectal Cancer

Abstract

Colorectal cancer (CRC) is one of the most common cancers worldwide. The diagnosis, prognosis and therapeutic monitoring of CRC depends largely on tissue biopsy. However, due to tumor heterogeneity and limitations such as invasiveness, high cost and limited applicability in longitudinal monitoring, liquid biopsy has gathered immense attention in CRC. Liquid biopsy has several advantages over tissue biopsy including ease of sampling, effective monitoring, and longitudinal assessment of treatment dynamics. Furthermore, the importance of liquid biopsy is signified by approval of several liquid biopsy assays by regulatory bodies indicating the powerful approach of liquid biopsy for comprehensive CRC screening, diagnostic and prognostics. Several liquid biopsy biomarkers such as novel components of the microbiome, non-coding RNAs, extracellular vesicles and circulating tumor DNA are extensively being researched for their role in CRC management. Majority of these components have shown promising results on their clinical application in CRC including early detection, observe tumor heterogeneity for treatment and response, prediction of metastases and relapse and detection of minimal residual disease. Therefore, in this review, we aim to provide updated information on various novel liquid biopsy markers such as a) oral microbiota related bacterial network b) gut microbiome-associated serum metabolites c) PIWI-interacting RNAs (piRNAs), microRNA(miRNAs), Long non-coding RNAs (lncRNAs), circular RNAs (circRNAs) and d) circulating tumor DNAs (ctDNA) and circulating tumor cells (CTC) for their role in disease diagnosis, prognosis, treatment monitoring and their applicability for personalized management of CRC.

Citing Articles

Liquid Biopsy and Colorectal Cancer.

Aggarwal S, Chougle A, Talwar V, Shukla P, Rohtagi N, Verma A South Asian J Cancer. 2025; 13(4):246-250.

PMID: 40060351 PMC: 11888811. DOI: 10.1055/s-0044-1801753.


Current Status of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer (CRC).

Somashekhar S, Surendran A, Goyal D, Rawat S, Aggarwal S, Selvasekar C South Asian J Cancer. 2025; 13(4):267-273.

PMID: 40060349 PMC: 11888813. DOI: 10.1055/s-0045-1802982.


The role of tumor-derived exosomal LncRNA in tumor metastasis.

Yu Z, Fu J, Mantareva V, Blazevic I, Wu Y, Wen D Cancer Gene Ther. 2025; .

PMID: 40011710 DOI: 10.1038/s41417-024-00852-x.


CircRNAs in colorectal cancer: potential roles, clinical applications, and natural product-based regulation.

Yang J, Fan Q, Wang Y, Liu Y, Xu X, Liang Y Front Oncol. 2025; 15:1525779.

PMID: 39944836 PMC: 11813906. DOI: 10.3389/fonc.2025.1525779.


Preoperative liquid biopsy transcriptomic panel for risk assessment of lymph node metastasis in T1 gastric cancer.

Ding P, Wu J, Wu H, Ma W, Li T, Yang P J Exp Clin Cancer Res. 2025; 44(1):43.

PMID: 39915770 PMC: 11804050. DOI: 10.1186/s13046-025-03305-x.


References
1.
Wu X, Zhang Y, Hu T, He X, Zou Y, Deng Q . A novel cell-free DNA methylation-based model improves the early detection of colorectal cancer. Mol Oncol. 2021; 15(10):2702-2714. PMC: 8486566. DOI: 10.1002/1878-0261.12942. View

2.
Fernandez-Lazaro D, Hernandez J, Garcia A, Cordova Martinez A, Mielgo-Ayuso J, Cruz-Hernandez J . Liquid Biopsy as Novel Tool in Precision Medicine: Origins, Properties, Identification and Clinical Perspective of Cancer's Biomarkers. Diagnostics (Basel). 2020; 10(4). PMC: 7235853. DOI: 10.3390/diagnostics10040215. View

3.
Chang S, Liew P, Ansar M, Lin S, Wang S, Hung C . Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction. Clin Epigenetics. 2020; 12(1):67. PMC: 7218647. DOI: 10.1186/s13148-020-00855-z. View

4.
Kerachian M, Javadmanesh A, Azghandi M, Mojtabanezhad Shariatpanahi A, Yassi M, Shams Davodly E . Crosstalk between DNA methylation and gene expression in colorectal cancer, a potential plasma biomarker for tracing this tumor. Sci Rep. 2020; 10(1):2813. PMC: 7028731. DOI: 10.1038/s41598-020-59690-0. View

5.
Ji W, Qiu C, Wang M, Mao N, Wu S, Dai Y . Hsa_circ_0001649: A circular RNA and potential novel biomarker for colorectal cancer. Biochem Biophys Res Commun. 2018; 497(1):122-126. DOI: 10.1016/j.bbrc.2018.02.036. View